Skip to main content
. 2023 May 24;37(6):590–600. doi: 10.1177/02698811231177216

Table 1.

Characteristics of participants.

Measure Non-hazardous (n = 50) Hazardous (n = 36)
Min Max M SD Min Max M SD
Age 18 80 37.40 18.83 18 70 28.00 14.41
AUDIT total 0 6 3.44 1.96 8 22 12.06 3.76
HADS anxiety 0 17 6.78 4.07 3 15 8.61 3.50
HADS depression 0 13 3.02 2.63 0 10 3.08 2.27
Gender Count Percentage Count Percentage
Female 36 72.0 21 58.3
Male 14 28.0 15 41.7
Educational level
 Levels 1 – 5 (secondary school – Cert/HNC/HND or equivalent) 19 38.0 21 58.3
 Level 6 (BSc, BA or equivalent) 10 20.0 4 11.1
 Levels 7 and 8 (MSc, MA, doctoral or equivalent) 16 32.0 6 16.7
 Trade, technical or vocational training (level unknown) 4 8.0 5 13.9
Employment status
 Full-time work 10 20.0 8 22.2
 Part-time work 13 26.0 14 38.9
 Student 8 16.0 5 13.9
 Retired 7 14.0 2 5.6
 Unemployed 12 24.0 7 19.4
Mental health disorders
 None 43 86.0 30 83.3
 Reported mental health condition (e.g. anxiety, personality, eating, neurodevelopmental) 7 14.0 6 16.7
Cognition impacting medication*
 No medication 34 68.0 27 75.0
 Medication which could impact cognition (including contraceptive pill, antidepressants, PPI or H1/H2 antagonist) 14 28 8 22.2
 Other medication not affecting cognition 2 4.0 1 2.8

HNC: Higher National Certificate; HND: Higher National Diploma; NSAID: non-steroidal anti-inflammatory drugs; PPI: proton pump inhibitors.

*

No participants took antiparkinsonian, antibiotic, antipsychotic, pain relief (opioid or NSAID), anticonvulsant, anxiolytic, alcohol-related or high-dose vitamin medications.